Alembic Ltd Reports Q2 Profit Growth Despite Revenue Softness

Q2 Net Profit: Rs 162.87 crore
Q2 Revenue from Operations: Rs 30.25 crore

Reader Takeaway: Profit rose on associate performance despite core business revenue contraction; investors must watch the ongoing electricity duty litigation.

What just happened

Alembic Ltd announced its financial results for the quarter ended September 30, 2026. The company saw its consolidated net profit rise to Rs 162.87 crore compared to Rs 128.49 crore in the same quarter last year. However, consolidated revenue from operations fell significantly to Rs 30.25 crore from Rs 55.86 crore in the year-ago period.

Why this matters

The growth in net profit appears driven by performance from associates rather than core operations. Both of the company's primary business segments, Active Pharmaceutical Ingredients (API) and Real Estate, recorded a decline in top-line figures compared to the previous year. The API segment revenue dropped to Rs 6.79 crore, while the Real Estate segment revenue fell to Rs 23.45 crore.

Risks to watch

The company's statutory auditors included an 'Emphasis of Matter' regarding a disputed electricity duty liability. Alembic has made a provision of Rs 20.52 crore for this matter, which involves a legal challenge against the State of Gujarat. The company has already deposited Rs 35 crore with the Supreme Court, and the ongoing appeal remains a key item for investors to monitor.

What to track next

Shareholders should track the recovery path of the Real Estate and API segments, as the decline in these core areas is noteworthy. Additionally, any further updates on the Supreme Court proceedings regarding the electricity duty liability will be critical to the company's legal and financial stability.